AOD-9604

A modified peptide mimicking the lipolytic (fat-burning) portion of HGH.

Mechanism:
AOD 9604 has been studied for its ability to stimulate lipolysis and inhibit lipogenesis, potentially influencing fat metabolism in adipose-rich areas by mimicking the lipolytic region of human growth hormone, without impacting growth factors or glucose levels.

Administration:
In preclinical studies, AOD 9604 has been administered via subcutaneous injection. Alternative forms, such as oral or transdermal delivery systems, have also been explored, though bioavailability may vary.

Potential Benefits:

Weight Loss and Fat Reduction:

1. In clinical settings, AOD 9604 has been studied for its potential to support fat metabolism. Some trials observed greater weight reduction when combined with diet and exercise, compared to placebo.
2. Notably, it appeared to target adipose tissue in areas such as the abdomen, hips, and thighs without significantly influencing appetite or cortisol levels.

Metabolic Health:

1. Does not significantly raise insulin-like growth factor-1 (IGF-1) levels or impair glucose tolerance, reducing risks of diabetes-like effects associated with full HGH.
2. May help maintain healthier blood glucose levels.

Musculoskeletal Health:

1. Preliminary studies indicate potential benefits for cartilage repair and bone density, possibly aiding conditions like osteoarthritis or osteoporosis.
2. May support muscle recovery and protein synthesis, useful in bodybuilding during cutting phases.

Other Claims:

1. Anecdotal reports suggest benefits for skin conditions (e.g., psoriasis, acne) and regenerative properties, though evidence is limited.